Published Aug 19, 2019

Angel-Funded Siamab Completes $202 Million Exit with Large Commercial-Stage Biopharma

Member News
Copy The Link to the  Article
Angel-Funded Siamab Completes $202 Million Exit with Large Commercial-Stage Biopharma
Copy The Link to the  Article

Related or similar articles

View more News
March 20, 2025

Labshares x BYTE51: A Game-Changing Partnership to Navigate Fundraising

Labshares News
June 28, 2024

Incubators vs. Shared Laboratories: Finding the Best Fit for Your Biotech Startup

Labshares News
March 13, 2019

Labshares Celebrates Grand Opening and Unveils Newly Expanded Shared Office and Lab Space in Newton

Labshares Newton's newly expanded facility features a cutting-edge lab and co-working space that can now accommodate up to 30 startups
Press Releases